CN Patent

CN109223791A — 脑癌的治疗

Assigned to Array Biopharma Inc · Expires 2019-01-18 · 7y expired

What this patent protects

本文提供用于治疗脑癌的化合物。本文还提供由用于治疗脑癌的那些化合物组成的药物组合物。

USPTO Abstract

本文提供用于治疗脑癌的化合物。本文还提供由用于治疗脑癌的那些化合物组成的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN109223791A
Jurisdiction
CN
Classification
—
Expires
2019-01-18
Drug substance claim
No
Drug product claim
No
Assignee
Array Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.